Hoff Elizabeth A Insider Trades

Insider Trading History

Track insider trading activity for Hoff Elizabeth A. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Artivion
Artivion AORT
Director
Holding Value $715k 34,765 shares
Last Trade
May 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$180k 7,576 shares
$23.76
$20.58
Artivion
Artivion AORT
Director
Holding Value $560k 27,189 shares
Last Trade
Nov 18, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$189k 4,200 shares
$45.10
$20.58
Artivion
Artivion AORT
Director
Holding Value $646k 31,389 shares
Last Trade
May 22, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$180k 6,325 shares
$28.46
$20.58
Cryolife
Cryolife CRY
Director
Holding Value $561k 31,389 shares
Last Trade
May 22, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$113k 6,325 shares
$17.88
$17.88
Artivion
Artivion AORT
Director
Holding Value $516k 25,064 shares
Last Trade
May 30, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$150k 6,289 shares
$23.85
$20.58
Artivion
Artivion AORT
Director
Holding Value $386k 18,775 shares
Last Trade
Jun 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$150k 9,709 shares
$15.45
$20.58
Artivion
Artivion AORT
Director
Holding Value $187k 9,066 shares
Last Trade
Nov 08, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$100k 9,066 shares
$11.03
$20.58

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up